Luka Mesin

Luka Mesin

@lukamesin.bsky.social

B-cell biologist.

416 followers145 following1 post

Luka Mesin reposted

This started in 2019 as daydreamy PhD student musings with Tatsuya Araki. We're as excited as ever about germinal centers as a platform for experimental evolution. Many thanks to PIs @victora.bsky.social @matsen.bsky.social, co-1st authors Ashni Vora and Tatsuya, and many other key collaborators!

cell.comReplaying germinal center evolution on a quantified affinity landscapeAntibody affinity maturation results from a somatic evolutionary process that takes place in the germinal center. A “parallel replay” experiment on germinal center B cells reveals the evolutionary for...

Read our latest preprint. A window into GC clonal evolution upon boost.

Gabriel Victora@victora.bsky.social

Happy to share our latest preprint on the clonal dynamics of GC “refueling.” We asked what happens at the clonal level after the simple (and ubiquitous) step of delivering a second vaccine dose during an ongoing GC response. www.biorxiv.org/content/10.6...

Luka Mesin reposted

Luka Mesin reposted

Luka Mesin reposted

I'm stoked to have this long-term and highly collaborative effort out in the wild. We present an experimental evolution system to quantitatively study the rapid evolutionary dynamics of B-cell affinity maturation. These evolutionary mechanisms underpin antibody responses and immune memory formation.

Gabriel Victora@victora.bsky.social

Wanted to highlight our latest preprint--a huge effort by multiple people and labs, but led primarily by @wsdewitt.github.io, Tatsuya Araki, and Ashni Vora, in a very close wet-dry collaboration with @matsen.bsky.social’s lab at the Hutch www.biorxiv.org/content/10.1...

Luka Mesin reposted

Luka Mesin reposted

Luka Mesin reposted

Luka Mesin reposted

Luka Mesin reposted

Check out our last pub. from @mfgrp.bsky.social al lab! We discovered that skin commensal microbes induce systemic and local B cell responses upon colonization and took advantage of this knowledge to create topical vaccines using engineered skin microbes. Please read the thread for details.

Michael Fischbach@mfgrp.bsky.social

Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent antibody response against a pathogen. Could lead to topical vaccines that are applied in a cream. @djenetbousbaine.bsky.social led the charge... @natureportfolio.bsky.social 1/55

You are up to date.